Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
Holding ABUS?
Track your performance easily

Arbutus Biopharma (ABUS) Financial Statements

1,210 Followers

Arbutus Biopharma Financial Overview

Arbutus Biopharma's market cap is currently ―. The company's EPS TTM is $-0.426; its P/E ratio is -8.80; Arbutus Biopharma is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.34M$ 1.73M$ 1.53M$ 2.15M$ 4.66M
Gross Profit$ 1.34M$ 1.73M$ 1.53M$ 2.15M$ 4.66M
EBIT$ -19.72M$ -19.76M$ -17.83M$ -19.27M$ -20.10M
EBITDA$ -19.38M$ -18.85M$ -17.48M$ -18.91M$ -19.73M
Net Income Common Stockholders$ -19.72M$ -19.52M$ -17.88M$ -19.31M$ -20.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 127.79M$ 141.99M$ 129.24M$ 126.00M$ 134.18M
Total Assets$ 140.44M$ 160.04M$ 150.29M$ 144.40M$ 158.64M
Total Debt$ 1.45M$ 1.60M$ 1.68M$ 1.77M$ 1.91M
Net Debt$ -126.35M$ -140.39M$ -127.56M$ -124.23M$ -132.27M
Total Liabilities$ 33.55M$ 37.59M$ 35.65M$ 38.38M$ 39.30M
Stockholders Equity$ 106.89M$ 122.45M$ 114.64M$ 106.02M$ 119.34M
Cash Flow-
Free Cash Flow$ -20.74M$ -14.51M$ -19.39M$ -17.29M$ -21.80M
Operating Cash Flow$ -20.74M$ -14.50M$ -19.30M$ -17.29M$ -21.78M
Investing Cash Flow$ -11.99M$ 9.83M$ 11.69M$ 22.23M$ 10.43M
Financing Cash Flow$ 1.77M$ 24.37M$ 24.43M$ 3.81M$ 1.68M
Currency in USD

Arbutus Biopharma Earnings and Revenue History

Arbutus Biopharma Debt to Assets

Arbutus Biopharma Cash Flow

Arbutus Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis